Transplantation Proceedings
Volume 32, Issue 7 , Pages 1493-1494 , November 2000

Immunologic monitoring: implications for treatment of rejection

  • M Suthanthiran

      Affiliations

    • Division of Nephrology, Department of Medicine, Weill Medical College of Cornell University, and Department of Transplantation Medicine, New York-Presbyterian Hospital, New York USA
    • Corresponding Author InformationAddress reprint requests to Manikkam Suthanthiran, 525 East 68th Street, Box 3, New York, NY 10021

References 

  1. Cecka JM, Terasaki PI. In Clinical Transplants 1992, edited by Terasaki PI, Cecka JM. Los Angeles, UCLA Tissue Typing Laboratory, p1–16, 1993
  2. Carpenter CB. Kidney Int. 1995;47:1491
  3. Solez K, Axelsen RA, Benediktsson H, et al.  Kidney Int. 1993;44:411
  4. Rappolee D, Mark D, Banda MJ, et al.  Science. 1988;241:708
  5. Lobe CG, Finlay BB, Paranchych W, et al: Science 232, 858, 1986
  6. Henkart PA. Immunity. 1994;1:343
  7. Heusel JW, Wesselschmidt RL, Shresta S, et al.  Cell. 1994;76:977
  8. Goldman M, Velu T: In Grünfeld J-P, Bach JF, Dreiss H, Maxwell MH (eds): St Louis: Mosby Year Book, Inc; 1995, p 79
  9. Sharma VK, Bologa RM, Li B, et al.  Transplantation. 1996;62:1860
  10. Xu G-P, Sharma VK, Li B, et al.  Kidney Int. 1995;48:1504
  11. Roberts AB, Sporn MB. Adv Cancer Res. 1988;51:107
  12. Sharma VK, Bologa RM, Xu G-P, et al.  Kidney Int. 1996;49:1297

PII: S0041-1345(00)01303-8

doi: 10.1016/S0041-1345(00)01303-8

Transplantation Proceedings
Volume 32, Issue 7 , Pages 1493-1494 , November 2000

Article Tools